Vicore Pharma Holding
16,76 SEK -1,3 %1 investor følger denne virksomhed
Vicore Pharma Holding is a pharmaceutical company. The company conducts research and development of molecules with agnostic effect, in industry terms called Renin-Angiotensin System (RAS), which affects the fluid and salt balance in the body. Vicore Pharma usually enters into licensing agreements with other pharmaceutical partners in the industry and has business operations at a global level. The company was founded in 2000 and is headquartered in Gothenburg.
Omsætning
-
EBIT %
-
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
NASDAQ Stockholm
VICO
Daglig lav / høj pris
16,6 / 17
SEK
Markedsværdi
1,37 mia. SEK
Aktieomsætning
348,87 t SEK
Volumen
21 t
Seneste videoer
Finanskalender
Delårsrapport
24.08.2023
Delårsrapport
02.11.2023
Årsrapport
28.02.2024
Viser Alle indholdstyper